A detailed history of Headlands Technologies LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 150 shares of CRL stock, worth $30,406. This represents 0.01% of its overall portfolio holdings.

Number of Shares
150
Holding current value
$30,406
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$203.52 - $273.43 $30,528 - $41,014
150 New
150 $40,000
Q3 2023

Nov 09, 2023

BUY
$194.44 - $217.61 $36,943 - $41,345
190 New
190 $37,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.3B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.